Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 10, 2003, Pages 4419-4426

  Richter, Markus ^a   Krauss, Achim H P ^b   Woodward, David F ^b   Lütjen Drecoll, Elke ^a,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b ALLERGAN INC   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (1 HYDROXYHEXYL)PHENYL] 5 OXOCYCLOPENTANEHEPTANOIC ACID; BIMATOPROST; LATANOPROST; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTAMIDE; SULPROSTONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR FLOW; ARTICLE; CELL ULTRASTRUCTURE; CILIARY MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON MICROSCOPY; HISTOPATHOLOGY; LONG TERM CARE; MONKEY; NERVE FIBER MEMBRANE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; TIME SERIES ANALYSIS; TISSUE FIXATION; TRABECULAR MESHWORK; TREATMENT OUTCOME; UVEOSCLERAL OUTFLOW;

ADMINISTRATION, TOPICAL; AMIDES; ANIMALS; ANTERIOR EYE SEGMENT; ANTIHYPERTENSIVE AGENTS; CILIARY BODY; DINOPROSTONE; INTRAOCULAR PRESSURE; LIPIDS; MACACA FASCICULARIS; MUSCLE, SMOOTH; NERVE FIBERS; OPHTHALMIC SOLUTIONS; PERIPHERAL NERVOUS SYSTEM; PROSTAGLANDINS F, SYNTHETIC; PROSTANOIC ACIDS; TRABECULAR MESHWORK;

EID: 0141430069     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-1281     Document Type: Article

References (28)

1. 2α-1-isopropylester in the cynomolgus monkey. Exp Eye Res. 1989;48:707-716.
2. Crawford K, Kaufman PL. Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of uveoscleral outflow by prostaglandin F2 alpha. Arch Ophthalmol. 1987;105:1112-1116.
3. 2α. Exp Eye Res. 1988;47:761-769.
4. 2α. An ultrastructural study in rhesus and cynomolgus monkeys. Mech Ageing Dev. 1990;51:101-120.
5. Lindsey JD, Weinreb RN. Effects of prostaglandins on uveoscleral outflow. In: Alm A, Weinreb RN, eds. Uveoscleral Outflow, Biology and Clinical Aspects. London, Mosby International;1998:41-55.
6. Lindsey JD, Kashiwagi K, Boyle D, Kashiwagi F, Firestein GS, Weinreb RN. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res, 1996;15:869-875.
7. Svedbergh B, Forsberg I. A morphological study on the effects of chronic administration of latanoprost (LP) on the ciliary muscle and trabecular meshwork in monkeys. Invest Ophthalmol Vis Sci. 1993;34:A1152-A1168.
8. 2-sensitive (EP) receptors. Adv PG Tx Lt Res. 1987;17:467-470.
9. 2 receptor agonist. Cardiovasc Drug Rev. 1993;11:165-179.
10. 2α-1-isopropyl ester to latanoprost: a review of the development of Xalatan. Invest Ophthalmol Vis Sci. 2001;42:1134-1145.
11. Woodward DF, Krauss AH-P, Chen J, et al. The pharmacology of bimatoprost (Lumigan™). Surv Ophthalmol. 2001;45:S337-S345.
12. Woodward DF, Krauss AH-P, Chen J, et al. Pharmacological characterization of a novel anti-glaucoma agent, bimatoprost (AGN 192024). J Pharmacol Exp Ther. 2003;305:772-785.
13. Stjernschantz J, Resul B. Phenyl substituted prostaglandin analogs for glaucoma treatment. Drugs Future. 1992;17:691-704.
14. 2 receptor. J Ocular Pharmacol Ther. 1995;11:447-454.
15. Woodward DF, Lawrence RA, Fairbairn CE, Shan T, Williams LS. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies. J Lipid Med. 1993;6:545-553.
16. 2α ester prodrugs and receptor selective prostaglandin analogs. J Ocular Pharmacol Ther. 1994;10:177-193.
17. Ito S, Karnovsky MJ. Formaldehyde-glutaraldehyde fixatives containing trinitro compounds. J Cell Biol. 1968;39:168a.
18. Lütjen-Drecoll E, Tamm E, Kaufman PL. Age-related loss of morphologic responses to pilocarpine in rhesus monkey ciliary muscle. Arch Ophthalmol. 1988;106:1591-1598.
19. Tamm ER, Lütjen-Drecoll E. Ciliary body. Microscopy Research and Technique. 1996;33:390-439.
20. Krebs W, Krebs IP. Ultrastructural evidence for lymphatic capillaries in the primate choroid. Arch Ophthlamol. 1988;106:1615-1616.
21. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp Eye Res. 1998;67:179-191.
22. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Implications for uveoscleral outflow. Surv Ophthalmol. 1997;42: S53-S59.
23. Lütjen-Drecoll E, Svedbergh B, Ober M, Kaufmann PL. Cytochalasin B-induced structural changes in the anterior ocular segment of the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1978;17:718-734.
24. 2 EDTA and EGTA on aqueous outflow routes in monkey eyes. Invest Optbalmol Vis Sci. 1980;19:492-504.
25. Weinreb RN, Mitchell MD. Prostaglandin production by cultured cynomolgus monkey trabecular meshwork cells. Prostaglandins Leukot Essent Fatty Acids. 1989;36:97-100.
26. Lütjen-Drecoll E, Kaufman PL, Eichhorn M. Long-term timolol and epinephrine in monkeys. I. Functional morphology of the ciliary processes. Trans Ophthalmol Soc UK. 1986;105:180.
27. Lütjen-Drecoll E, Wiendl H, Kaufman PL. Acute and chronic structural effects of pilocarpine on monkey outflow tissues. Tr Am Ophth Soc 1998;XCVI:171-195.
28. Lütjen-Drecoll E, Kaufman PL. Echothiophate-induced structural alterations in the anterior chamber angle of the cynomolgus monkey. Invest Ophtahlmol Vis Sci. 1979;18:918-929.